The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALTIMMUNE INC | COM | 02155H200 | 59,400 | 4,500,000 | SH | SOLE | 4,500,000 | 0 | 0 | ||
| ALX ONCOLOGY HOLDINGS INC | COM | 00166B105 | 11,322 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| ATHIRA PHARMA INC | COM | 04746L104 | 28,089 | 1,521,623 | SH | SOLE | 1,521,623 | 0 | 0 | ||
| BCTG ACQUISITION CORP | COM | 05492W103 | 5,180 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 18,049 | 1,271,985 | SH | SOLE | 1,271,985 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC | COM | 15117B202 | 11,864 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICAL | COM | 210373106 | 81,382 | 4,016,873 | SH | SOLE | 4,016,873 | 0 | 0 | ||
| FS DEVELOPMENT CORP-A | COM CL A | 303020101 | 5,599 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| GALERA THERAPEUTICS INC | COM | 36338D108 | 467 | 51,653 | SH | SOLE | 51,653 | 0 | 0 | ||
| HUMANIGEN INC | COM | 444863104 | 24,818 | 2,332,516 | SH | SOLE | 2,332,516 | 0 | 0 | ||
| IMV INC | COM | 44974L103 | 17,760 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
| KEROS THERAPEUTICS INC | COM | 492327101 | 25,931 | 672,306 | SH | SOLE | 672,306 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 17,618 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 15,329 | 1,192,883 | SH | SOLE | 1,192,883 | 0 | 0 | ||
| MEDICENNA THERAPEUTICS CORP | COM | 58490H107 | 383 | 92,453 | SH | SOLE | 92,453 | 0 | 0 | ||
| METACRINE INC | COM | 59101E103 | 11,677 | 1,143,673 | SH | SOLE | 1,143,673 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 25,147 | 668,440 | SH | SOLE | 668,440 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 26,757 | 3,877,895 | SH | SOLE | 3,877,895 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 9,235 | 625,710 | SH | SOLE | 625,710 | 0 | 0 | ||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 2,598 | 107,982 | SH | SOLE | 107,982 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM | 89620X506 | 102,377 | 7,204,577 | SH | SOLE | 7,204,577 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 903214104 | 10,191 | 4,355,273 | SH | SOLE | 4,355,273 | 0 | 0 | ||